Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02468999Completed
Randomised, double-blind trial in insulin resistance (IR) comparing Insulin Nasal Spray with Placebo Nasal Spray (2 arms). Primary endpoints: Glucose Infusion Rate, Endogenous Glucose Production and 1 more. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02468999.